Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - MetaStat, Inc. | ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of
1934
Date of
Report (Date of Earliest Event Reported): June 16,
2017
MetaStat,
Inc.
(Exact
name of registrant as specified in its charter)
Nevada
(State
or other jurisdiction of incorporation)
|
000-52735
|
20-8753132
|
|
(Commission File
Number)
|
(IRS Employer
Identification No.)
|
27 Drydock Avenue, 2nd Floor
Boston,
MA 02210
(Address
of principal executive offices and zip code)
(617)
531-6500
(Registrant's
telephone number including area code)
(Registrant's
former name or former address, if changed since last
report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of registrant under
any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
[ ]
Soliciting material pursuant to Rule 14a-12(b) under the Exchange
Act (17 CFR 240.14a-12(b))
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Entry into a Material Definitive
Agreement.
On June
16, 2017, MetaStat, Inc. ( “MetaStat”) received
payment of $243,371 from Celgene Corporation (“Celgene”) for
satisfactory completion of the second milestone pursuant to the
pilot materials transfer agreement, as amended on September 29,
2016 (the “Research
Agreement”) between the parties. MetaStat has received
$730,112 in aggregate from Celgene pursuant to the Research
Agreement.
A copy
of the press release is attached hereto as Exhibit
99.1.
Item 9.01. Financial Statement and
Exhibits.
(d)
Exhibits.
|
Exhibit
No.
|
|
Description
|
|
|
|
|
|
99.1
|
|
Press
Release dated June 19, 2017.
|
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the Registrant
has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
|
|
METASTAT,
INC.
|
|
|
|
|
|
|
|
|
|
By:
|
/s/
Douglas
A. Hamilton
|
|
|
|
|
Name: Douglas A.
Hamilton
|
|
|
|
|
Title:
President and
CEO
|
|
|
|
|
|
|
|
Dated: June
19, 2017
|
|
|
|